Unilabs strengthens its presence in Madrid
Unilabs announced today that its wholly-owned subsidiary Unilabs Espa?a has signed an agreement to buy 100% of the shares of Labipath, a leading clinical laboratory in Madrid. Labipath had revenues in excess of Euros 1.6 million in 2004, and maintains 7 phlebotomy centers in Madrid receiving an average of 300 patients per day. Labipath also provides laboratory services to two major Madrid hospitals: Clínica Belen and Hospital Venerable Orden Tercera de San Francisco de Asís.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Long-COVID - all a question of genes? - New study results show possible risk factor
Beckman Coulter and Fujirebio enter into partnership - The goal is a patient-friendly, blood-based Alzheimer's disease test
Beta cells from stem cells: Potential for cell replacement therapy - Quality control with CD177 can help save lots of time, efforts and money
Clinical Reference Laboratory Inc to build European laboratory hub in UK
The evolution of cancer cells decoded - "Our vision is a new type of early cancer detection"
Protagen Deepens Cooperation With Bayer Schering Pharma
Seeing a diagnosis: How an eye test could aid Alzheimer's detection
C-mo Medical Solutions raises €4.1 million aiming to transform cough monitoring
New technique for testing drugs to treat cystic fibrosis and epilepsy
Neuronal Parkinson inclusions are different than expected - Study raises new questions about the etiology of Parkinson’s disease
Analytik Jena Sells Site in Eisfeld - New investor acquiring entire Optics business unit as well as component production for analytical technology